Study on the efficacy and mechanism of repetitive transcranial magnetic stimulation of the precuneus in the treatment of patients with amnestic mild cognitive impairment

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
INTERVENTION: real group:repetitive Transcranial Magnetic Stimulation;sham group:pseudo‐stimulus coil;healthy control group:None; CONDITION: amnestic mild cognitive impairment PRIMARY OUTCOME: the change in baseline compared to the total score of the Montreal Cognitive Assessment Scale (MoCA); SECONDARY OUTCOME: Auditory Verbal Learning Test (AVLT);Minimum Mental State Examination (MMSE);Symbol Digit Modalities Test (SDMT);Trail Making Test‐B (TMT‐B);Changes in brain functional connectivity;Changes in brain electrical activity frequency, power, distribution, and spatiotemporal dynamics of brain networks; INCLUSION CRITERIA: 1. aMCI group: (1) Age: 55 to 80 years old, gender not limited. (2) Right‐handed. (3) Have a junior high school education or above, possess certain reading and writing skills, and be capable of completing the content of this research. (4) Meet Petersen's diagnostic criteria: 1) Have a chief complaint of memory decline; 2) Disease course >3 months; 3) Scale assessment: Global Deterioration Scale (GDS) rating was 2 to 3, Clinical Dementia Scale(GDS) was 0.5 points, and the memory test score was 1.5 standard deviations in the age and education matched control group, MMSE >= 24 points, MOCA < 26 points, and the score of the Activities of Daily Living Scale (ADL‐20 items) is higher than 21 points; d.Memory impairment is the main symptom, while other cognitive domains remain relatively intact. (5) Geriatric Depression Scale (GDS) < 7. (6) Hachinski Ischemia Inde X(HIS) <= 4. (7) Medial temporal lobe atrophy Visual Scale (MTA‐scale) < 2 poin
Epistemonikos ID: caeb8a1f268d58715c1556d8c902e6d2b3948303
First added on: Oct 08, 2026